Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 58, pseudogene (RN7SL58P)
- Target
- RN7SL58P
- Molecular classification
- Pseudogene, Non-coding RNA derivative, Other (not a receptor, enzyme, transporter, ion channel, transcription factor, or histone modifier)
01
Overview
RNA, 7SL, cytoplasmic 58, pseudogene (RN7SL58P) is a non-protein coding RNA sequence classified as a pseudogene, derived from the parental functional 7SL RNA gene that is a critical component of the signal recognition particle (SRP) complex. Unlike functional 7SL RNAs, which are central to SRP-mediated protein targeting to the endoplasmic reticulum, RN7SL58P does not encode an active transcript for canonical SRP function. While some pseudogenes have regulatory impacts through RNA-mediated mechanisms, no specific biological functions, disease implications, or drug interactions have been characterized for RN7SL58P itself. Pseudogenes generally can influence gene expression by acting as competitive endogenous RNAs or miRNA sponges, but specific evidence for RN7SL58P is lacking.
- Other names
- RN7SL58PRNA, 7SL, cytoplasmic 58, pseudogene
02
Biological functions
No direct functionPseudogenes in general can have regulatory roles, such as serving as competitive endogenous RNAs (ceRNAs)Pseudogenes in general can act as miRNA decoysPseudogenes in general can modulate posttranscriptional regulation of protein coding genes
03
Disease associations
Other (RN7SL58P itself is not implicated, but pseudogenes are involved in regulation related to cancer, immune response, and proliferation in some contexts)
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 58, pseudogene (RN7SL58P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 58, pseudogene (RN7SL58P).